ReseaRch Quality assuRance foR the futuRe a ... - Lund University

Panel 14 – chemistry
and facility collaboration within the University, nationally and internationally.
In the competitive globalized world of education and research, this
requirement to identify, focus and expand on areas of excellence, whether
at the level of faculty, departments, groups and individuals is critical. This
will be an important component to delivering the overall aim of ensuring
the University focusses on areas that have the potential to attain research
and education of the highest international standard.
5.2 Overall assessment
The overall quality assessment of the Department of Immunotechnology
is ‘excellent’. The department is internationally recognized for its research
excellence, technology developments, its commercialization and the
relevance and importance of its biomedical and clinical applications. It
has been at the international fore-front in its areas of research over many
years. This department is known internationally for the high quality
and rigor of its research and critically combines multi-disclipinary and
interdisciplinary expertise in complementary areas of technology development,
antibody libraries, arrays and applications, proteomics, clinical
and commercial collaborations, biomarker discovery and bioinformatics
analysis.
5.3 Research infrastructure
Organisation: The Department of Immunotechnology was formally
inaugurated in 2007, when the Department of Immunotechnology
(previously part of the Chemical Center) and the Unit for Protein Technology
(previously part of the Department of Electrical Measurements)
merged and re-located to be closer to the medical faculty to increase and
strengthen the inter-faculty collaborative programs. The department is
organized into 5 research groups headed by a Full Professor level, Prof.
Carl Borrebaeck; comprising;
(i) Cancer targets
(ii) Antibody engineering/molecular evolution
(iii) Allergy
(iv) Proteomics
(v) Antibody microarray
413